Content about Cardiology

December 21, 2011

The Food and Drug Administration has approved a new drug for high blood pressure made by Takeda, the drug maker said.

DEERFIELD, Ill. — The Food and Drug Administration has approved a new drug for high blood pressure made by Takeda, the drug maker said.

The Japanese drug maker received approval for Edarbyclor (azilsartan medoxomil and chlorthalidone) for the treatment of high blood pressure, also known as hypertension. The company called it the only fixed-dose therapy that combines an angiotensin II receptor blocker with chlorthalidone, a diuretic, in a once-daily, single tablet. The company also markets Edarbi, which only contains azilsartan medoxomil.

December 20, 2011

A hike in blood pressure during middle age significantly raises the risk of having a heart attack or a stroke, according to new Northwestern Medicine research released Monday.

CHICAGO — A hike in blood pressure during middle age significantly raises the risk of having a heart attack or a stroke, according to new Northwestern Medicine research released Monday. The study offers a new understanding on the importance of maintaining low blood pressure early in middle age to prevent heart disease later in life.

December 14, 2011

Nonin Medical on Monday announced that its GO2 Personal Finger Pulse Oximeter was featured on "The Balancing Act" program on Lifetime Television on Dec. 13.

MINNEAPOLIS — Nonin Medical on Monday announced that its GO2 Personal Finger Pulse Oximeter was featured on "The Balancing Act" program on Lifetime Television on Dec. 13.

Yvonne Leonard, Nonin Medical consumer products marketing manager, shared with viewers how knowing their oxygen saturation and pulse rate can help them manage chronic respiratory conditions such as chronic obstructive pulmonary disease.

November 28, 2011

A study published online earlier this month by the American Journal of Cardiology concluded that supplementation with vitamin D conferred substantial survival benefits, specifically in patients with documented deficiency.

KANSAS CITY, Kan. — A study published online earlier this month by the American Journal of Cardiology concluded that supplementation with vitamin D conferred substantial survival benefits, specifically in patients with documented deficiency.

According to the research, evidence supported an association between vitamin D deficiency and hypertension, peripheral vascular disease, diabetes mellitus, metabolic syndrome, coronary artery disease and heart failure.

October 19, 2011

Many of this country's 80 million baby boomers who take medications for such conditions as pain, high cholesterol, hypertension and even depression are not aware that some of those medications could lead them to seek relief from occasional constipation.

STAMFORD, Conn. — Many of this country's 80 million baby boomers who take medications for such conditions as pain, high cholesterol, hypertension and even depression are not aware that some of those medications could lead them to seek relief from occasional constipation, according to a nationwide survey of 1,150 men and women age 50 years or older taking medications for common medical conditions released by Purdue Products Wednesday.

October 14, 2011

Despite declines in the number of Americans reporting coronary heart disease, rates vary widely between states and between racial and ethnic groups, according to a new study by the Centers for Disease Control and Prevention.

ATLANTA — Despite declines in the number of Americans reporting coronary heart disease, rates vary widely between states and between racial and ethnic groups, according to a new study by the Centers for Disease Control and Prevention.

October 11, 2011

Patients with one or more of four chronic diseases who take their medications as prescribed may save the healthcare system as much as $7,800 per patient annually, according to the findings of a CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period.


Patients with one or more of four chronic diseases who take their medications as prescribed may save the healthcare system as much as $7,800 per patient annually, according to the findings of a CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period.


October 7, 2011

It seems that boosting high-density lipoproteins levels, also known as "good" cholesterol, can help diabetes patients reduce their risk of heart attack and stroke, according to a new study conducted by Kaiser Permanente published in the American Journal of Cardiology.

PORTLAND, Ore. — It seems that boosting high-density lipoproteins levels, also known as "good" cholesterol, can help diabetes patients reduce their risk of heart attack and stroke, according to a new study conducted by Kaiser Permanente published in the American Journal of Cardiology.

September 28, 2011

Chelsea Therapeutics International has applied for Food and Drug Administration approval of a drug for a disorder that affects patients with diseases like Parkinson's disease.

CHARLOTTE, N.C. — Chelsea Therapeutics International has applied for Food and Drug Administration approval of a drug for a disorder that affects patients with diseases like Parkinson's disease.

The drug maker announced the submission of a new drug application for Northera (droxidopa) as a treatment for neurogenic orthostatic hypotension. NOH predominantly affects people with primary autonomic failure, a group of diseases that includes Parkinson's, multiple system atrophy and pure autonomic failure.

September 14, 2011

As part of the launch of the Department of Health and Human Services' Million Hearts campaign on Tuesday, HHS identified several key association partners, including the National Community Pharmacist Association and the American Pharmacists Association.

ALEXANDRIA, Va. — As part of the launch of the Department of Health and Human Services' Million Hearts campaign on Tuesday, HHS identified several key association partners, including the National Community Pharmacist Association and the American Pharmacists Association.

September 13, 2011

Singer and atrial fibrillation patient Barry Manilow has joined Sanofi's national education campaign designed to raise awareness about atrial fibrillation.

NEW YORK — Singer and atrial fibrillation patient Barry Manilow has joined Sanofi's national education campaign designed to raise awareness about atrial fibrillation.

The Get Back in Rhythm campaign aims to improve the health and well-being of those affected by the condition by encouraging them to learn more about the risks and talk with their healthcare provider about how to maintain a normal heart rhythm and manage the disease.

July 22, 2011

A drug designed to boost high-density lipoprotein cholesterol levels also may improve blood-sugar control for diabetics, according to a new analysis of a discontinued study.

NEW YORK — A drug designed to boost high-density lipoprotein cholesterol levels also may improve blood-sugar control for diabetics, according to a new analysis of a discontinued study.

Australian researchers found that torcetrapib, a cholesteryl ester transfer protein inhibitor, could improve HDL or "good" cholesterol levels while improving blood-sugar control among diabetics.

June 20, 2011

CVS/pharmacy spent the last couple of months sponsoring nearly 300 free screening and consultation events in Atlanta, Washington, D.C., and Philadelphia targeting African-American communities. 


Part of the chain’s To Your Health program, the events were an extension of the A Su Salud events targeting Hispanic customers in Los Angeles, Dallas, Houston and Miami. To Your Health started in Atlanta on April 17, moving on to Washington, D.C., on June 12 and Philadelphia on June 19.


May 24, 2011

A drug made by Daiichi-Sankyo was safe and effective in maintaining reductions in blood pressure in older patients, according to a new study presented at the American Society of Hypertension’s 26th annual meeting in New York.

PARSIPPANY, N.J. — A drug made by Daiichi-Sankyo was safe and effective in maintaining reductions in blood pressure in older patients, according to a new study presented at the American Society of Hypertension’s 26th annual meeting in New York.

The “TRINITY” study of Tribenzor (olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide) showed the drug was well-tolerated and effective in patients ranging in age from younger than 65 years to older than 65 years, after a year.

April 27, 2011

A biopharmaceutical company has appointed a new CFO.

CAMBRIDGE, Mass. — A biopharmaceutical company has appointed a new CFO.

Aegerion Pharmaceuticals named Mark Fitzpatrick as the company's new CFO. Fitzpatrick joins the company, which is focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, from Proteon Therapeutics, where he served as VP, CFO and assistant secretary.

April 15, 2011

Takeda Pharmaceutical has launched a new treatment for high blood pressure, the company said Friday.

DEERFIELD, Ill. — Takeda Pharmaceutical has launched a new treatment for high blood pressure, the company said Friday.

Takeda announced the launch of Edarbi (azilsartan medoxomil), which the Food and Drug Administration approved on Feb. 25 as a once-daily pill for hypertension.

March 30, 2011

Wegmans Food Markets on Tuesday introduced new resources for patients concerned about blood pressure and how to best manage their numbers at the Wegmans pharmacy counter.

ROCHESTER, N.Y. — Wegmans Food Markets on Tuesday introduced new resources for patients concerned about blood pressure and how to best manage their numbers at the Wegmans pharmacy counter. Wegmans also is hosting a blood pressure page on Wegmans.com, where patients can watch seven short videos on ways toward good readings.

March 15, 2011

A drug under investigation as a treatment for a rare genetic disorder that causes abnormally high triglyceride levels in the blood has received orphan-drug designation from the Food and Drug Administration.

CAMBRIDGE, Mass. — A drug under investigation as a treatment for a rare genetic disorder that causes abnormally high triglyceride levels in the blood has received orphan-drug designation from the Food and Drug Administration.

March 1, 2011

A new study published in Hypertension: Journal of the American Heart Association established a link between high blood pressure and the consumption of such beverages as soda and other sugar-sweetened drinks.

DALLAS — A new study published in Hypertension: Journal of the American Heart Association established a link between high blood pressure and the consumption of such beverages as soda and other sugar-sweetened drinks.

February 28, 2011

The Food and Drug Administration has approved a new treatment for hypertension, also known as high blood pressure, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for hypertension, also known as high blood pressure, the agency said Friday.

The FDA approved Takeda’s Edarbi (azilsartan medoxomil).

February 24, 2011

Drug maker Takeda has filed for regulatory approval of a drug to treat hypertension, the company said Wednesday.

OSAKA, Japan — Drug maker Takeda has filed for regulatory approval of a drug to treat hypertension, the company said Wednesday.

Takeda announced that it had submitted an application with the Food and Drug Administration for the fixed-dose drug azilsartan medoxomil and chlorthalidone. Azilsartan medoxomil is an angiotensin II receptor blocker, or ARB, that lowers blood pressure by blocking the angiotensin II hormone.

February 24, 2011

The Spaniards drink Rioja wine with a hearty “Salud!,” while the Irish knock back Jameson whiskey and Guinness beer with “Slainte.” Nobody can say who coined the two calls to imbibe, both of which mean “health,” but according to two recent studies, it looks as though they were on to something.

NEW YORK — The Spaniards drink Rioja wine with a hearty “Salud!,” while the Irish knock back Jameson whiskey and Guinness beer with “Slainte.” Nobody can say who coined the two calls to imbibe, both of which mean “health,” but according to two recent studies, it looks as though they were on to something.

February 22, 2011

In line with American Heart Month, Boehringer Ingelheim's Micardis has introduced a cardiovascular risk-reduction calculator, designed to assess patients' cardiovascular risk.

NEW YORK — In line with American Heart Month, Boehringer Ingelheim's Micardis has introduced a cardiovascular risk-reduction calculator, designed to assess patients' cardiovascular risk.

The calculator, which can be accessed at MicardisPro.com, is an interactive, useful tool for healthcare professionals to assist patients in reaching their cardiovascular risk-reduction goal, the company said.

Micardis (telmisartan) is a drug designed to treat hypertension.

February 18, 2011

ROCHESTER, N.Y. — Blood-pressure kiosks have become a ubiquitous site in retail pharmacies across the country, but like pharmacy automation and technology as a whole, they’re continuing to advance and offer new features.

February 4, 2011

The cardiovascular drug market will turn into a difficult conquest in the years to come as it increasingly will be dominated by generics, but that isn’t stopping drug companies from continuing to develop treatments — 299 of them, according to a recent report by the Pharmaceutical Research and Manufacturers of America — for high cholesterol, hypertension, atrial fibrillation, heart failure and other heart-related conditions.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The cardiovascular drug market will turn into a difficult conquest in the years to come as it increasingly will be dominated by generics, but that isn’t stopping drug companies from continuing to develop treatments — 299 of them, according to a recent report by the Pharmaceutical Research and Manufacturers of America — for high cholesterol, hypertension, atrial fibrillation, heart failure and other heart-related conditions.